Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Valmont Industries Executive VP Acquires Shares in Recent Transaction

Valmont Industries, Inc. has disclosed a recent transaction involving the acquisition of its common stock by John L. Schwietz, the Executive Vice President and Chief Financial Officer. This development is noteworthy for investors as it reflects insider confidence in the company's performance and future …

Manish Choudhary | 24 July 2026

Patricia Gallup Reports Significant Stock Sales Under 10b5-1 Plan at PC Connection

PC Connection, Inc. has disclosed that Patricia Gallup, the Chairman and Chief Administrative Officer, executed multiple stock sales on July 22 and 23, 2026. This activity was conducted under a Rule 10b5-1 trading plan established earlier this year. Investors may be interested in the …

Anjali Anand | 24 July 2026

Marsh & McLennan Companies Reports Significant Stock Transaction by Director

Marsh & McLennan Companies, Inc. has disclosed a significant stock transaction involving its director, Lloyd M. Yates. The transaction, reported on July 24, 2026, involves the sale of 12,000 shares of common stock. This development is noteworthy for investors as it reflects insider activity …

Manish Choudhary | 24 July 2026

Planet Labs PBC Executive Transfers Shares Under Rule 10b5-1 Trading Plan

Planet Labs PBC has reported significant share transactions involving its President and CFO, Ashley F. Johnson. The transactions, executed under a Rule 10b5-1 trading plan, indicate strategic moves in the management's ownership structure. Investors may find this update relevant as it reflects the company's …

Anjali Anand | 24 July 2026

Travel & Leisure Co. Executive Reports Significant Stock Sale Amid Administrative Corrections

Travel & Leisure Co. recently disclosed a transaction involving the sale of a substantial amount of common stock by Chief Human Resources Officer Kimberly Marshall. This move, along with corrections to previously reported figures, may attract investor attention regarding the company's executive ownership structure …

Aakashdeep | 24 July 2026

Bank of Montreal Launches New Auto-Callable Securities Linked to Micron and NVIDIA Stocks

Bank of Montreal has filed a preliminary pricing supplement detailing its latest offering of senior medium-term notes, which are categorized as market-linked securities. These securities are designed to be auto-callable and feature a contingent coupon with a memory feature. The offering is linked to …

Vinay Lochav | 24 July 2026

Bank of Montreal Launches New Contingent Risk Notes Linked to Russell 2000 Index

The recent announcement from Bank of Montreal details the issuance of Senior Medium-Term Notes, Series K, valued at $1,472,000. These notes are designed to appeal to investors seeking exposure to the Russell 2000 Index, which is often viewed as a benchmark for small-cap U.S. …

Anjali Anand | 24 July 2026

Bank of Montreal Launches New Contingent Risk Absolute Return Buffer Notes Linked to NASDAQ-100 Index

On July 24, 2026, Bank of Montreal filed a disclosure regarding the issuance of its Senior Medium-Term Notes, Series K. This financial product is specifically designed for investors who are looking for a return linked to the performance of the NASDAQ-100 Index. The total …

Vinay Lochav | 24 July 2026

Inspire Medical Systems Announces Appointment of New Board Member Michael H. Carrel

Inspire Medical Systems, Inc. has appointed Michael H. Carrel to its Board of Directors, effective immediately. This strategic addition is expected to enhance the company's governance and oversight as it continues to expand its presence in the medical device sector. Investors may view this …

Anjali Anand | 24 July 2026

MannKind Corporation Secures $50 Million in Private Placement Following FDA Approval of Furoscix ReadyFlow

MannKind Corporation has successfully completed a private placement, raising approximately $50 million from institutional investors. This funding comes on the heels of the U.S. Food and Drug Administration's approval of Furoscix ReadyFlow™, a treatment for edema in adults with heart failure or chronic kidney …

Aakashdeep | 24 July 2026
Support

Hi! How can we help you today?

Loading…